Loading...

ACADIA Pharmaceuticals Inc.

ACAD•NASDAQ
Healthcare
Biotechnology
$21.96
$-0.15(-0.68%)
U.S. Market opens in 49h 27m

ACADIA Pharmaceuticals Inc. (ACAD) Stock Overview

Explore ACADIA Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.7B
P/E Ratio9.50
EPS (TTM)$2.30
ROE0.42%
Fundamental Analysis

AI Price Forecasts

1 Month$20.38
3 Months$27.07
1 Year Target$27.90

ACAD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ACADIA Pharmaceuticals Inc. (ACAD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $27.90.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.50 and a market capitalization of 3.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.68%
5-Day Change
0.50%
1-Month Change
4.77%
3-Month Change
-18.18%
6-Month Change
-0.27%
Year-to-Date (YTD) Change
-17.78%
1-Year Change
48.08%
3-Year Change
9.04%
5-Year Change
2.86%
All-Time (Max) Change
227.76%

Contact Information

https://www.acadia-pharm.com
858 558 2871
12830 El Camino Real, San Diego, CA, 92130

Company Facts

653 Employees
IPO DateMay 27, 2004
CountryUS
Actively Trading

Frequently Asked Questions